NEW YORK, Sept. 5 – Cheminformatics company Tripos has struck a deal with Schering AG to help the German drug giant integrate its compound research and inventory data and perform chemical tracking, Tripos said on Wednesday.
Under the deal, Tripos will allow Schering to use its ChemCore tracking system to become more efficient in the way it develops novel chemical entities, Tripos said.
The collaboration represents the first one of its kind for the ChemCore system, which incorporates Tripos’ MetaLayer technology, a company spokeswoman said.
“ChemCore…will support Schering researchers in all aspects of chemical compound production, including reagent ordering, inventory management, compound and reaction searching, and registration of new compounds,” Tripos said in a statement.
Financial terms of the agreement were not disclosed.
The spokeswoman said that St. Louis-based Tripos has other European and American pharmaceutical companies interested in its technology, but would not specify which companies those are. These deals will be announced “in the near future,” she added.